The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: A prospective cohort study

Javier Murillas, Antonio Rimola, Montserrat Laguno, Elisa de Lazzari, Javier Rascón, Fernando Agüero, José L. Blanco, Eduardo Moitinho, Asunción Moreno, José M. Miró, ESLD‐HIV Working Group Investigators – 28 August 2009 – End‐stage liver disease (ESLD) has become the main cause of mortality in patients coinfected by human immunodeficiency virus (HIV) and hepatitis B virus or hepatitis C virus in developed countries. The aim of this study was to describe the natural history of and prognostic factors for ESLD, with particular attention paid to features affecting liver transplantation.

Renal outcomes after liver transplantation in the model for end‐stage liver disease era

Pratima Sharma, Kathy Welch, Richard Eikstadt, Jorge A. Marrero, Robert J. Fontana, Anna S. Lok – 28 August 2009 – The proportion of patients undergoing liver transplantation (LT) with renal insufficiency has significantly increased in the Model for End‐Stage Liver Disease (MELD) era. This study was designed to determine the incidence and predictors of post‐LT chronic renal failure (CRF) and its effect on patient survival in the MELD era. Outcomes of 221 adult LT recipients who had LT between February 2002 and February 2007 were reviewed retrospectively.

Liver transplantation following donation after cardiac death: An analysis using matched pairs

James K. Pine, Amer Aldouri, Alistair L. Young, Mervyn H. Davies, Magdy Attia, Giles J. Toogood, Stephen G. Pollard, J. P. A. Lodge, K. R. Prasad – 28 August 2009 – Grafts from donation after cardiac death (DCD) donors are used to increase the number of organs available for liver transplantation. There is concern that warm ischemia may impair graft function. We compared our DCD recipients with a case‐matched group of donation after brain death (DBD) recipients. Between January 2002 and April 2008, 39 DCD grafts were transplanted.

Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B

Natalie Bzowej, Steven Han, Bulent Degertekin, Emmet B. Keeffe, Sukru Emre, Robert Brown, Rajender Reddy, Anna S. Lok, National Institutes of Health Hepatitis B Virus Orthotopic Liver Transplantation Study Group – 28 August 2009 – Several previous studies found that Asians transplanted for hepatitis B virus (HBV) infection had worse post‐transplant outcomes than Caucasians. Data on post‐transplant outcomes of African Americans and waitlist outcomes of Asian Americans and African Americans with hepatitis B are scant.

Liver transplantation using uncontrolled non–heart‐beating donors under normothermic extracorporeal membrane oxygenation

Santos Jiménez‐Galanes, Marchán Juan Carlos Meneu‐Diaz, Almudena Moreno Elola‐Olaso, Baltasar Pérez‐Saborido, Fundora‐Suarez Yiliam, Alberto Gimeno Calvo, Manuel Abradelo Usera, Mercedes Catalán González, Juan Carlos Montejo González, Enrique Moreno González – 28 August 2009 – Because of the organ shortage, non–heart‐beating donors have been proposed as a possible source of grafts for orthotopic liver transplantation (OLT).

Subscribe to